longevity science
Longevity Science vs Multivitamin Drinks Loses Detox Battle A 2023 randomized trial showed a 23% drop in liver enzymes after 90 days of a science-based detox supplement, proving it outperforms multivitamin drinks for liver health. In busy office settings, targeted supplements protect the liver while sugary diets strain it, making
longevity science
Rapamycin vs Metformin: Longevity Science Showdown Rapamycin shows stronger lifespan extension in animal models but carries higher toxicity, making its translation to human longevity a calculated trade-off. In the recent Phase 2b trial, more than 700 middle-aged participants received a weekly 4-mg rapamycin dose, revealing a 12% reduction in age-related
longevity science
Fasting can indeed slow the genetic aging clock, according to the 2025 Longevity Alliance study. The research followed over 13,000 adults for a decade, revealing measurable reductions in mortality and epigenetic age acceleration. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always
longevity science
CO₂ breathwork is a breathing technique that can extend healthspan by improving cellular oxygen efficiency. I’ll explain why this matters, how it works, and how to practice it safely. In 2023, a study published in the Journal of Applied Physiology reported a 15% increase in mitochondrial efficiency among participants
longevity science
Longevity Science vs Intermittent Fasting: Hidden Cost? A 2023 analysis found that moving dinner 2-4 hours earlier can add roughly 10 days of healthspan to a typical 70-year-old. In short, intermittent fasting (IF) looks promising for longevity, but we need to weigh hidden costs such as adherence fatigue and modest
longevity science
Longevity Science Exposed Liver Cleanse Myths Harm Your Health Popular liver cleanse products often promise a reset of your body, but the reality is that most of these regimens do not improve liver function and can actually jeopardize health. In my reporting, I’ve spoken with researchers, clinicians, and manufacturers
longevity science
Shift Focus Mouse Models vs Human Longevity Science In 2025 a meta-analysis showed 94% of longevity interventions that succeeded in mouse trials failed in phase II human studies, indicating that mouse models are the bottleneck for translating longevity science to people. I believe the field must rethink its reliance on
longevity science
Cutting Gene-Editing Costs vs Screening: Longevity Science Wins In 2024, 70% of aging-focused venture capital went to biomarker startups, showing that cheap diagnostics beat pricey gene edits for longevity gains. I explain why shifting dollars from high-cost genome editing to scalable screening tools makes more sense for biotech firms seeking
longevity science
Over 60% of published longevity studies suffer from critical demographic bias, and that bias is siphoning money from academic budgets while slowing progress. The skewed participant pools, short dosing windows, and shifting endpoints turn promising science into costly dead ends. Medical Disclaimer: This article is for informational purposes only and
longevity science
The Apple Watch outperforms the Garmin Forerunner for senior healthspan monitoring, thanks to its superior sensor fidelity and integration with longevity-science data. I’ve seen families choose the watch that keeps aging biomarkers in check, and the evidence backs that choice. In 2024, a randomized trial involving 750 seniors showed
longevity science
Intermittent Fasting and Longevity: Evidence, Protocols, and Real-World Outcomes Intermittent fasting can modestly improve markers of longevity, but the magnitude depends on the fasting window, individual health status, and consistency. Researchers have documented benefits ranging from reduced inflammation to slower epigenetic aging, while critics highlight mixed results in weight loss
longevity science
7 Longevity Science Mistakes Wrecking Trials In 2025, a JCI meta-analysis showed that relying on telomere length alone raises false-positive rates by 32% in Phase II longevity trials. Did you know that the most cited longevity biomarkers might actually be misleading? Learn how the wrong metric selection could cost decades